Dr. Vasudevan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Suite 1210
Houston, TX 77030Phone+1 832-822-3135Fax+1 832-825-3141
Summary
- I am a general pediatric surgeon specializing in surgical oncology. My primary focus is in children with complex pancreatic and hepatobiliary tumors such as Hepatoblastoma, HCC, UESL, benign liver tumors, solid pseudopapillary neoplasms of the pancreas and pancreaticoblastoma. I also have specialized expertise in neuroblastoma, endocrine tumors (pheochromocytoma, PNET), and soft tissue sarcoma.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Surgery, 2009 - 2011
- Baylor College of MedicineResidency, Surgery, 2001 - 2009
- Emory University School of MedicineClass of 2001
Certifications & Licensure
- TX State Medical License 2011 - 2025
- OK State Medical License 2014 - 2015
- American Board of Surgery Surgery
- American Board of Surgery Pediatric Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 34 citationsSurgical Management of Hepatoblastoma and Recent Advances.Tianyou Yang, Richard S. Whitlock, Sanjeev A. Vasudevan
Cancers. 2019-12-04 - 342 citationsDiagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.D. Williams Parsons, Angshumoy Roy, Yaping Yang, Tao Wang, Sarah Scollon
JAMA Oncology. 2016-05-01 - 36 citationsEffects of socioeconomic status on children with well-differentiated thyroid cancerEvan F. Garner, Ilan I. Maizlin, Matthew Dellinger, Kenneth W. Gow, Melanie Goldfarb
Surgery. 2017-09-01
Press Mentions
- Fluorescent Dye Helps Guide Pediatric Liver Tumor ResectionMay 20th, 2021
- Novel Combination Therapy Offers Promising Results for Treatment-Refractory HepatoblastomaFebruary 22nd, 2024
- Promising Results from Novel Combo Therapy for Stubborn HepatoblastomaMarch 2nd, 2024
Grant Support
- Mkp-8: Novel Phosphatase Overexpressed In NeuroblastomaNational Cancer Institute2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: